AI is revolutionizing healthcare by diagnosing cancers in early stages and aiding in cures for genetic diseases like sickle cell and beta thalassemia.
ARK Invest research indicates that AI could reduce the cost of developing a new drug from $2.4 billion to $600 million within five years and decrease the timeline from 13 years to as few as eight.
This efficiency in drug development could shift the U.S. healthcare system towards preventative care and cures, potentially transforming the industry.
AI's impact on healthcare goes beyond autonomous vehicles and humanoid robots, with the most profound applications expected in the healthcare sector.